Illumina ILMN
NASDAQ ILMN
$227.74 +2.90 (+1.29%)
As of: Aug 27, 2026 · 3:59 PM EDT

Illumina (ILMN) Amortization of Deferred Charges (2020 - 2021)

Illumina (ILMN) posted quarterly Amortization of Deferred Charges of $10.0 million for Q2 2021, little changed year-over-year from $10.0 million in Q2 2020, and little changed on a QoQ basis from $10.0 million in Q1 2020.

Illumina (ILMN) Amortization of Deferred Charges (2020 - 2021) Analysis & Trends

Illumina has reported Amortization of Deferred Charges for 2 years, with the latest figure at $10.0 million in Q2 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 234.15 Bn 230.09 Bn 8.34 Bn
2 Danaher 152.10 Bn 147.75 Bn 3.61 Bn
3 Natera 48.48 Bn 47.38 Bn 486.15 Mn
4 Agilent Technologies 44.35 Bn 42.55 Bn 990.00 Mn
5 Iqvia Holdings 43.68 Bn 41.60 Bn 1.44 Bn
6 Idexx Laboratories 43.02 Bn 42.83 Bn 779.09 Mn
7 Illumina 34.39 Bn 33.22 Bn 770.00 Mn
8 Mettler Toledo International 28.29 Bn 28.24 Bn 650.22 Mn
9 Labcorp Holdings 27.51 Bn 27.37 Bn 1.11 Bn
10 Quest Diagnostics 27.10 Bn 26.47 Bn 1.03 Bn

Historic Data

Download Data
DateValue
Apr 4, 2021 10.00 Mn
Apr 4, 2021 10.00 Mn
Mar 29, 2020 10.00 Mn
Mar 29, 2020 10.00 Mn